Company Overview and News

 
Cramer: In a US-China trade war, there are not enough winners

18h cnbc
As stocks sank on Thursday, CNBC's Jim Cramer inspected the market for the various triggers that sparked the decline.
Upvote Downvote

 
TSMC's smartphone warning points squarely at Apple - analysts

22h channelnewsasia
Shares in Apple Inc and its suppliers fell on Thursday after a raft of analysts read a prediction of softer smartphone sales from Taiwan Semiconductor Manufacturing Co Ltd as driven chiefly by concern about demand for iPhones.
Upvote Downvote

 
TSMC's smartphone warning points squarely at Apple: analysts

2018-04-19 channelnewsasia
Shares in Apple Inc and its suppliers fell on Thursday after a raft of analysts read a prediction of softer smartphone sales from Taiwan Semiconductor Manufacturing Co Ltd as driven chiefly by concern about demand for iPhones.
Upvote Downvote

 
TSMC's smartphone warning points squarely at Apple: analysts

2018-04-19 reuters
(Reuters) - Shares in Apple Inc (AAPL.O) and its suppliers fell on Thursday after a raft of analysts read a prediction of softer smartphone sales from Taiwan Semiconductor Manufacturing Co Ltd (2330.TW) as driven chiefly by concern about demand for iPhones.
Upvote Downvote

1
7 Stocks With Massive Earnings Potential

2018-04-12 investorplace
True, the markets are shaky right now. Prices plunged on trade war fears and are now rising again as China tries to diffuse the tension. We are certainly in the midst of an unpredictable trading season. However, if there is one thing that can give the market a big kick right now, it’s earnings season. And not just any earnings season.
Upvote Downvote

 
Concerned About A Global Trade War? Here Is What To Avoid And What To Buy

2018-04-09 seekingalpha
U.S. stocks have seen spikes of volatility as investors are unsettled with the prospect of Trump's trade war against China and its threat to economic growth. While it is unclear how much further a potential trade war would drag down the stock market, we believe that short-term adverse political impacts on the market generally present long-term buying opportunities.
Upvote Downvote

 
SWKS / Skyworks Solutions, Inc. null

2018-04-06 sec.gov
Shareholder Memo Vote against t
Upvote Downvote

 
Once-hot semi stocks are in a correction. Here's why some are shrugging off the pain

2018-04-04 cnbc
Semiconductor stocks were among last year's hottest trades, as names like Nvidia, Applied Materials and Broadcom posted double- and triple-digit returns. Fast-forward to this year, and the once-hot chip stocks have quickly fallen out of favor with investors and into correction territory.
Upvote Downvote

 
Chipmakers may have the most to lose in a trade war with China

2018-04-04 cnbc
Semiconductors may be the sector most affected by rising trade tensions between the U.S. and China.
Upvote Downvote

1
Don't Be Fooled by These China-Focused Tech Stocks

2018-04-02 zacks
After a stellar ride, the technology sector witnessed wild swings in March thanks to the decline in FANG stocks and other high-technology names. The tech onslaught stemmed from a slew of negative news from some of the key companies in the space. Behind The Plunge The initial panic was created by Facebook (FB - Free Report) after the data breach report that sparked concerns about data privacy and security, and will likely lead to increased scrutiny and possible regulatory pressure.
Upvote Downvote

 
Is Intel's Tariffs Risk Real?

2018-03-29 seekingalpha
Given more than 43% cost exposure from Asian tech imports, Intel potentially has a lot to lose with Trump’s 25% tariffs.
Upvote Downvote

 
Trump Tariffs' Impact On Apple

2018-03-27 seekingalpha
Given more than 90% cost exposure from Asian tech imports, Apple has a significant stake in Trump’s 25% tariffs.
Upvote Downvote

1
Stocks To Watch: Back To School For Apple

2018-03-24 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 83088M102